化療市場：依藥物、癌症類型、給藥途徑、通路、地區分類

Chemotherapy Market, By Drugs, By Cancer Type, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年11月25日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年化療市場規模為108.7億美元，預計2031年將達183.5億美元，2024年至2031年複合年成長率為7.8%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	108.7億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	7.80%	預計金額（2031年）	183.5億美元

圖：2024 年化療市場佔有率（%），依地區分類

化療是一種癌症治療方法，使用一種或多種抗癌藥物作為標準化化療方案的一部分。化療藥物的作用是減緩或阻止癌細胞的生長，癌細胞的生長、分裂和擴散速度比正常細胞更快。化療用於治療多種類型的癌症，包括乳癌、肺癌、大腸癌、淋巴瘤、白血病、膀胱癌、睪丸癌和卵巢癌。化療通常透過靜脈注射，但也可以口服或局部給藥。化療通常按週期進行，每個治療期之後都有一個恢復期，在此期間身體會產生健康的新細胞。副作用因所用藥物、劑量和患者而異，但可能包括疲勞、食慾不振、噁心、嘔吐、脫髮、口腔炎和免疫力下降。

市場動態：

各種類型癌症盛行率的上升和老年人口的增加（越來越容易罹患癌症）是預計未來幾年推動化療市場成長的關鍵因素。此外，對標靶藥物治療和個人化醫療的需求不斷成長、藥物傳輸系統的技術進步以及臨床開發中新型化療藥物的強大管道可能會進一步推動市場擴張。然而，化療藥物的副作用、抗藥性風險、抗癌藥物高成本、新興國家缺乏醫療基礎設施和意識等可能會在整個預測期內在一定程度上抑制市場。降低毒性、提高療效的創新藥物輸送系統的開發以及抗癌藥物的靶向輸送為該市場的參與企業帶來了廣闊的機會。

本研究的主要特點

本報告詳細分析了全球化療市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR，%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
基於公司亮點、產品系列、主要亮點、業績和策略等參數的全球化療市場主要企業的概況。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、產品創新、市場擴張和行銷策略做出明智的決策。
全球化療市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球化療市場的各種策略矩陣來促進他們的決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	10.87 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.80%	2031 Value Projection:	18.35 Bn

Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy drugs work by slowing or stopping the growth of cancer cells which grow, divide, and spread more rapidly than normal cells. Chemotherapy is used to treat many types of cancers including breast cancer, lung cancer, colorectal cancer, lymphoma, leukemia, bladder cancer, testicular cancer, ovarian cancer, and others. It is often given intravenously but can also be given by mouth or topically. Chemotherapy is usually given in cycles with each period of treatment followed by a recovery period to allow the body to build healthy new cells. Side effects depend on the specific drugs used, dosage, and the patient but can include fatigue, loss of appetite, nausea, vomiting, hair loss, mouth sores, and lowered immunity.

Market Dynamics:

The rising prevalence of various types of cancers and the growing geriatric population, which is increasingly susceptible to developing cancer, are significant factors expected to drive the growth of the chemotherapy market in the coming years. Additionally, the increasing demand for targeted drug therapies and personalized medicine, along with technological advancements in drug delivery systems and a strong pipeline of novel chemotherapy agents in clinical development, will further enhance market expansion. However, the toxicity and side effects associated with chemotherapy drugs, risk of drug resistance, high costs of cancer drugs, and lack of healthcare infrastructure and awareness in developing countries are likely to restrain the market to a certain extent over the forecast period. Development of innovative drug delivery systems to reduce toxicity and improve efficacy and targeted delivery of anti-cancer drugs hold promising opportunities for players in this market.

Key Features of the Study:

This report provides in-depth analysis of the global chemotherapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chemotherapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bristol-Myers Squibb Company, AstraZeneca, Pfizer Inc., Novartis AG, GSK plc., Sanofi, Amgen Inc., Gilead Sciences, Inc., Boehringer Ingelheim International GmbH., AbbVie Inc., Merck & Co., Inc., Eureka Therapeutics, Inc., Verismo Therapeutics, Inc., Bayer AG, and Autolus Therapeutics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global chemotherapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chemotherapy market

Market Segmentation

By Drugs Insights (Revenue, USD Bn, 2019 - 2031)
- Alkylating agents
- Antimetabolites
- Anti-tumor antibiotics
- Others
By Cancer Type Insights (Revenue, USD Bn, 2019 - 2031)
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Blood Cancer
- Liver Cancer
- Others
By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Bristol-Myers Squibb Company
- AstraZeneca
- Pfizer Inc.
- Novartis AG
- GSK plc.
- Sanofi
- Amgen Inc.
- Gilead Sciences, Inc.
- Boehringer Ingelheim International GmbH.
- AbbVie Inc.
- Merck & Co., Inc.
- Eureka Therapeutics, Inc.
- Verismo Therapeutics, Inc.
- Bayer AG
- Autolus Therapeutics

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Chemotherapy Market, By Drugs
- Chemotherapy Market, By Cancer Type
- Chemotherapy Market, By Route of Administration
- Chemotherapy Market, By Distribution Channel
- Chemotherapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Epidemiology

4. Global Chemotherapy Market, By Drugs, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Alkylating agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antimetabolites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anti-tumor antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Chemotherapy Market, By Cancer Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Chemotherapy Market, By Route of Administration, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Chemotherapy Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Chemotherapy Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drugs, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Cancer Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
Boehringer Ingelheim International GmbH.
AbbVie Inc.
Merck & Co., Inc.
Eureka Therapeutics, Inc.
Verismo Therapeutics, Inc.
Bayer AG
Autolus Therapeutics